446 related articles for article (PubMed ID: 29620278)
1. GPNMB silencing suppresses the proliferation and metastasis of osteosarcoma cells by blocking the PI3K/Akt/mTOR signaling pathway.
Jin R; Jin YY; Tang YL; Yang HJ; Zhou XQ; Lei Z
Oncol Rep; 2018 Jun; 39(6):3034-3040. PubMed ID: 29620278
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p.
Song L; Zhou Z; Gan Y; Li P; Xu Y; Zhang Z; Luo F; Xu J; Zhou Q; Dai F
J Cell Biochem; 2019 Jun; 120(6):9656-9666. PubMed ID: 30548308
[TBL] [Abstract][Full Text] [Related]
3. Heat shock protein 90B1 plays an oncogenic role and is a target of microRNA-223 in human osteosarcoma.
Li G; Cai M; Fu D; Chen K; Sun M; Cai Z; Cheng B
Cell Physiol Biochem; 2012; 30(6):1481-90. PubMed ID: 23208072
[TBL] [Abstract][Full Text] [Related]
4. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
Zhang Y; Cheng H; Li W; Wu H; Yang Y
Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
[TBL] [Abstract][Full Text] [Related]
5. AIM2 inhibits the proliferation, invasion and migration, and promotes the apoptosis of osteosarcoma cells by inactivating the PI3K/AKT/mTOR signaling pathway.
Zheng J; Liu C; Shi J; Wen K; Wang X
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913077
[TBL] [Abstract][Full Text] [Related]
6. P53 suppresses cell proliferation, metastasis, and angiogenesis of osteosarcoma through inhibition of the PI3K/AKT/mTOR pathway.
Song R; Tian K; Wang W; Wang L
Int J Surg; 2015 Aug; 20():80-7. PubMed ID: 25936826
[TBL] [Abstract][Full Text] [Related]
7. Isoliquiritigenin Suppresses Osteosarcoma U2OS Cell Proliferation and Invasion by Regulating the PI3K/Akt Signalling Pathway.
Chen J; Liu C; Yang QQ; Ma RB; Ke Y; Dong F; Wu XE
Chemotherapy; 2018; 63(3):155-161. PubMed ID: 29936511
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene.
Li KW; Wang SH; Wei X; Hou YZ; Li ZH
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12655-12666. PubMed ID: 33378012
[TBL] [Abstract][Full Text] [Related]
9. ZIC2 promotes viability and invasion of human osteosarcoma cells by suppressing SHIP2 expression and activating PI3K/AKT pathways.
Huang S; Jin A
J Cell Biochem; 2018 Feb; 119(2):2248-2257. PubMed ID: 28857346
[TBL] [Abstract][Full Text] [Related]
10. SIX1 reduces the expression of PTEN via activating PI3K/AKT signal to promote cell proliferation and tumorigenesis in osteosarcoma.
Yu C; Zhang B; Li YL; Yu XR
Biomed Pharmacother; 2018 Sep; 105():10-17. PubMed ID: 29807230
[TBL] [Abstract][Full Text] [Related]
11. HER4 promotes the growth and metastasis of osteosarcoma via the PI3K/AKT pathway.
Li X; Huang Q; Wang S; Huang Z; Yu F; Lin J
Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):345-362. PubMed ID: 32181480
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
Shang Y; Wang LQ; Guo QY; Shi TL
Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
[TBL] [Abstract][Full Text] [Related]
13. LncRNA LINC00628 overexpression inhibits the growth and invasion through regulating PI3K/Akt signaling pathway in osteosarcoma.
He R; Wu JX; Zhang Y; Che H; Yang L
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5857-5866. PubMed ID: 30280767
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumoral potential of MDA19 in human osteosarcoma via suppressing PI3K/Akt/mTOR signaling pathway.
Liu B; Xu L; Dai EN; Tian JX; Li JM
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30442873
[TBL] [Abstract][Full Text] [Related]
15. RILP inhibits tumor progression in osteosarcoma via Grb10-mediated inhibition of the PI3K/AKT/mTOR pathway.
Wei Z; Xia K; Zheng D; Gong C; Guo W
Mol Med; 2023 Oct; 29(1):133. PubMed ID: 37789274
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA‑22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Xue HQ; Sun L; Sun C; Feng W; Guo SB
Oncol Rep; 2020 Apr; 43(4):1169-1186. PubMed ID: 32323781
[TBL] [Abstract][Full Text] [Related]
17. [microRNA-16-5p targeted tetraspanin 15 gene to inhibit the proliferation, migration and invasion of osteosarcoma cell through phospoinositide 3-kinase/protein kinase B signaling pathway].
Yu JB; Zhang HJ; Yan LW; Chang F; Jia ZW; Yang XR
Zhonghua Yi Xue Za Zhi; 2020 Jun; 100(21):1668-1675. PubMed ID: 32486604
[No Abstract] [Full Text] [Related]
18. The Effects of Interleukin-33 (IL-33) on Osteosarcoma Cell Viability, Apoptosis, and Epithelial-Mesenchymal Transition are Mediated Through the PI3K/AKT Pathway.
Wang S; Zhao G; Zhao S; Qiao Y; Yang H
Med Sci Monit; 2020 Apr; 26():e920766. PubMed ID: 32312946
[TBL] [Abstract][Full Text] [Related]
19. LINC00968 functions as an oncogene in osteosarcoma by activating the PI3K/AKT/mTOR signaling.
Liu G; Yuan D; Sun P; Liu W; Wu PF; Liu H; Yu GY
J Cell Physiol; 2018 Nov; 233(11):8639-8647. PubMed ID: 29904919
[TBL] [Abstract][Full Text] [Related]
20. BTG2 inhibits the proliferation and metastasis of osteosarcoma cells by suppressing the PI3K/AKT pathway.
Li YJ; Dong BK; Fan M; Jiang WX
Int J Clin Exp Pathol; 2015; 8(10):12410-8. PubMed ID: 26722427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]